These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6344364)

  • 21. A new in vitro test for pyrimethamine/sulfadoxine susceptibility of Plasmodium falciparum and its correlation with in vivo resistance in Kenya.
    Spencer HC; Watkins WM; Sixsmith DG; Koech DK; Chulay JD
    Bull World Health Organ; 1984; 62(4):615-21. PubMed ID: 6386209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pyrimethamine/sulfadoxine resistant falciparum malaria in East Africa.
    Timmermanns PM; Hess U; Jones ME
    Lancet; 1982 May; 1(8282):1181. PubMed ID: 6122952
    [No Abstract]   [Full Text] [Related]  

  • 23. Development of an in vitro microtest for determining the susceptibility of Plasmodium falciparum to sulfadoxine-pyrimethamine: laboratory investigations and field studies in Port-au-Prince, Haiti.
    Nguyen-Dinh P; Payne D; Teklehaimanot A; Zevallos-Ipenza A; Day MM; Duverseau YT
    Bull World Health Organ; 1985; 63(3):585-92. PubMed ID: 3899394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross resistance of pyrimethamine and sulfadoxine to their related compounds in Plasmodium falciparum.
    Tan-ariya P; Brockelman C
    Southeast Asian J Trop Med Public Health; 1984 Mar; 15(1):7-11. PubMed ID: 6377515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pyrimethamine/sulfadoxine resistant falciparum malaria acquired at Dar es Salaam, Tanzania.
    Stahel E; Degrémont A; Lagler U
    Lancet; 1982 May; 1(8281):1118-9. PubMed ID: 6122905
    [No Abstract]   [Full Text] [Related]  

  • 26. Fansidar-resistant falciparum malaria in Papua New Guinea.
    Darlow B; Vrbova H; Stace J; Heywood P; Aalpers M
    Lancet; 1980 Dec; 2(8206):1243. PubMed ID: 6108409
    [No Abstract]   [Full Text] [Related]  

  • 27. Susceptibility of Plasmodium falciparum to pyrimethamine and sulfadoxine/pyrimethamine in Kisumu, Kenya.
    Nguyen-Dinh P; Spencer HC; Chemangey-Masaba S; Churchill FC
    Lancet; 1982 Apr; 1(8276):823-5. PubMed ID: 6122056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasmodium falciparum in Haiti: susceptibility to pyrimethamine and sulfadoxine-pyrimethamine.
    Nguyen-Dinh P; Zevallos-Ipenza A; Magloire R
    Bull World Health Organ; 1984; 62(4):623-6. PubMed ID: 6386210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mefloquine and sulfadoxine/pyrimethamine resistant Plasmodium falciparum.
    Arnold K
    Lancet; 1986 Jan; 1(8473):154. PubMed ID: 2867368
    [No Abstract]   [Full Text] [Related]  

  • 30. Concurrent chloroquine and Fansidar resistance of Plasmodium falciparum: an imported case from Gabon.
    Burchard GD; Winkler E
    Trop Geogr Med; 1988 Jan; 40(1):68-9. PubMed ID: 3289215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Falciparum malaria resistant to chloroquine, quinine and Fansidar in a non-immune patient infected in Ghana.
    Nguyen C; Gregson D; Mouldey P; Keystone JS
    Trans R Soc Trop Med Hyg; 1989; 83(4):485-6. PubMed ID: 2694485
    [No Abstract]   [Full Text] [Related]  

  • 32. Mefloquine-pyrimethamine-sulfadoxine combination delays emergence of mefloquine resistant Plasmodium falciparum in continuous culture.
    Tan-Ariya P; Brockelman CR; Menabandhu C
    Southeast Asian J Trop Med Public Health; 1984 Dec; 15(4):531-5. PubMed ID: 6398918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo assessment of the sensitivity of Plasmodium falciparum to sulphadoxine/pyrimethamine combination (Fansidar) in six localities in Tanzania where chloroquine-resistant P. falciparum has been detected.
    Kilimali VA; Mkufya AR
    Trans R Soc Trop Med Hyg; 1985; 79(4):482-3. PubMed ID: 3909553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and molecular monitoring of Plasmodium falciparum resistance to antimalarial drug (artesunate+sulphadoxine-pyrimethamine) in two highly malarious district of Madhya Pradesh, Central India from 2012-2014.
    Mishra S; Bharti PK; Shukla MM; Ali NA; Kashyotia SS; Kumar A; Dhariwal AC; Singh N
    Pathog Glob Health; 2017 Jun; 111(4):186-194. PubMed ID: 28549390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-resistant malaria.
    Lancet; 1981 Nov; 2(8255):1087-8. PubMed ID: 6118530
    [No Abstract]   [Full Text] [Related]  

  • 36. [Polyresistance of asiatic P. falciparum to chloroquine and pyrimethamine-sulfadoxine combination. Apropos of a new case].
    Pays JF; Hugues FC
    Bull Soc Pathol Exot Filiales; 1981; 74(4):406-13. PubMed ID: 7028296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fansidar resistant Plasmodium falciparum infection in Surinam.
    Oostburg BF; Jozefzoon LM
    Trop Geogr Med; 1983 Sep; 35(3):243-7. PubMed ID: 6359597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of the response in vivo and in vitro of Plasmodium falciparum to sulphadoxine-pyrimethamine in the malarious areas of Iran.
    Edrissian GH; Afshar A; Sayedzadeh A; Mohsseni G; Satvat MT
    J Trop Med Hyg; 1993 Aug; 96(4):237-40. PubMed ID: 8345544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimal concentration of p-aminobenzoic acid and folic acid in the in vitro assay of antifolates against Plasmodium falciparum.
    Tan-ariya P; Brockelman CR; Menabandhu C
    Am J Trop Med Hyg; 1987 Jul; 37(1):42-8. PubMed ID: 3300393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic polymorphisms associated with sulphadoxine-pyrimethamine drug resistance among Plasmodium falciparum field isolates in malaria endemic areas of Assam.
    Sharma J; Dutta P; Khan SA; Soni M; Dey D; Mahanta J
    J Postgrad Med; 2015; 61(1):9-14. PubMed ID: 25511211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.